These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8092756

  • 61. Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV.
    Briguglio F, Briguglio E, Di Marco V, Swat M, Materia G, Intilisano A.
    J Int Med Res; 1986; 14(3):115-23. PubMed ID: 3721052
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. [Treatment of frostbites. Analysis of results in twenty patients with buflomedil chlorhydrate (author's transl)].
    Foray J, Baisse PE, Mont JP, Cahen C.
    Sem Hop; 1986; 56(9-10):490-7. PubMed ID: 6244676
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. [Value of buflomedil in vascular radiology of hepatoma].
    Emery JC, Genin G, Bonvoisin S, Croisille M.
    Ann Radiol (Paris); 1994; 37(6):441-8. PubMed ID: 7702337
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Increase in plasma levels of adenosine and adenine nucleotides after intravenous infusion of buflomedil in humans.
    Capecchi PL, Laghi Pasini F, Sodi N, Chiavetta M, Sensi S, De Lalla A, Volpi L, Di Perri T.
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):35-9. PubMed ID: 7723351
    [Abstract] [Full Text] [Related]

  • 69. Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011.
    Bucolo C, Longo L, Camillieri G, Drago F, Salomone S.
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1190-6. PubMed ID: 22855302
    [Abstract] [Full Text] [Related]

  • 70. [Can vasomotion be modified by vasoactive substances or hemodilution?].
    Tischler R, Decrinis M, Skursky-Roller R.
    Acta Med Austriaca; 1994 Nov; 21(5):133-6. PubMed ID: 7709711
    [Abstract] [Full Text] [Related]

  • 71. [Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial].
    Natali J, Kieny R, Le Bas P, Benhamou M, Molkhou JM.
    Ann Cardiol Angeiol (Paris); 1989 Jun; 38(6):339-42. PubMed ID: 2667444
    [No Abstract] [Full Text] [Related]

  • 72. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
    Longo FN, Potortì F, Urbano O, Perroni GB.
    Minerva Cardioangiol; 1988 May; 36(5):249-52. PubMed ID: 3059229
    [No Abstract] [Full Text] [Related]

  • 73. [The effects of terazosin hydrochloride and buflomedil in patients with hemicrania without aura].
    Paterna S, Martino S, Ingurgio NC, Arrostuto A, Correo S, Licata G.
    Clin Ter; 1994 Apr; 144(4):307-19. PubMed ID: 7911406
    [Abstract] [Full Text] [Related]

  • 74. Assessment of collateral perfusion: a pharmacodynamic study with buflomedil hydrochloride.
    Labs KH, Eichlisberger R, Jeanneret C, Frauchiger B, Aschwanden M, Jäger KA.
    Angiology; 2000 Apr; 51(4):301-8. PubMed ID: 10779000
    [Abstract] [Full Text] [Related]

  • 75. The effect of buflomedil in diabetic retinopathy estimated by ocular fluorophotometry.
    Kjaergaard JJ, Ditzel J.
    Int J Microcirc Clin Exp; 1987 Aug; 6(3):257-63. PubMed ID: 3308731
    [Abstract] [Full Text] [Related]

  • 76. [Acral skin circulation following intra-arterial infusion of vasodilating substances in patients with intermittent claudication].
    Scheffler A, Rieger H.
    Med Klin (Munich); 1990 Jan 15; 85(1):1-5. PubMed ID: 2314351
    [Abstract] [Full Text] [Related]

  • 77. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G, Baldoni F, Peruzzi G, Raimondi G, Grimaldi I, Visigalli G, Gristina S, Massaro M, De Martinis L, Sangiorgi M.
    Cardiologia; 1983 Aug 15; 28(8):651-60. PubMed ID: 6687209
    [No Abstract] [Full Text] [Related]

  • 78. The value of population pharmacokinetics and simulation for postmarketing safety evaluation of dosing guidelines for drugs with a narrow therapeutic index: buflomedil as a case study.
    Bourguignon L, Ducher M, Matanza D, Bleyzac N, Uhart M, Odouard E, Maire P, Goutelle S.
    Fundam Clin Pharmacol; 2012 Apr 15; 26(2):279-85. PubMed ID: 22004557
    [Abstract] [Full Text] [Related]

  • 79. [Effect of buflomedil on microcirculation of the skin in acral gangrene].
    Fagrell B, Hermansson IL.
    Fortschr Med; 1985 Jan 10; 103(1-2):23-7. PubMed ID: 3882535
    [No Abstract] [Full Text] [Related]

  • 80. [Systolic pressure index at the ankle, a "beacon" of long-term monitoring of lower-limb arteriopathy].
    Becker F, Brenot R, Perrin M.
    J Mal Vasc; 1985 Jan 10; 10 Suppl A():37-42. PubMed ID: 3928793
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.